Currently, Doug is CEO of Health2047, an AMA-funded integrated innovation company based in San Francisco that is focused on improving healthcare at a system-level. Additionally, he serves as chairman of the board at both Arrowhead Research (NASDAQ: ARWR) and Vivaldi Biosciences, and is a managing partner at G5 Partners, a Silicon Valley strategic advisory and venture investment firm. Previously, Doug was an investment partner at Bay City Capital, where he was involved in more than 45 investments in life sciences companies. An M.D. who holds a Ph.D in virology, Doug’s areas of expertise span biotechnology, biopharmaceuticals, specialty medical products, and healthcare innovation.

Get involved

Want to explore the frontiers of science and medical research,
and empower a community while doing so?


Our volunteers are our greatest asset

Wondering how you can serve our mission, and join one extraordinary team of dedicated people?

Read more


We cannot do without you!

Become a Sponsor of the Accademia di Gagliato and enjoy the privileges and rewards of an exclusive membership

Read more


Get In Touch

Subscribe to our newsletter for regular updates or contact us.


Log in

Login to your account

Username *
Password *
Remember Me